The Karaganda pharmaceutical complex plans to release two million doses of the Russian Sputnik V coronavirus vaccine by early June as part of an agreement with Moscow. This is reported by TASS with reference to the government commission to prevent the spread of coronavirus in Kazakhstan.
The corresponding agreement between the Russian Direct Investment Fund (RDIF) and the Ministry of Health of Kazakhstan will be concluded in the near future. The project for increasing vaccine production capacity itself is supervised by the governments of the two countries, the commission stressed.
It is noted that the pilot batch of Sputnik V, produced in the Kazakhstani complex, has already passed the quality check at the National Research Center for Epidemiology and Microbiology named after N.F. Gamalei. It became known that it received the approval of specialists, and the company has already been allowed to start mass production.
Kazakhstan launched a mass production of the Russian coronavirus vaccine on its territory at the end of December 2020. Mass vaccination against the infection began in the country on February 1. In turn, the chief sanitary doctor of the country Yerlan Kiyasov and the deputy minister of health Azhar Giniyat have already been vaccinated with Sputnik V. Health Minister Alexei Tsoi decided to wait for the Kazakhstani vaccine.